The U.S. Food and Drug Administration recently cleared for marketing the first over-the-counter (OTC) continuous glucose monitor (CGM) for children, Dexcom Inc.’s Stelo Glucose Biosensor System, an integrated CGM (iCGM) indicated for people two years of age and older who do not use insulin. The FDA previously cleared the Stelo Glucose Biosensor System OTC for individuals 18 years and older in March 2024.
Many people with type 2 diabetes take medications after metformin to control blood sugar, but not all of those drugs behave the same in the body. Type 2 diabetes doesn’t just raise blood sugar — it also increases the risk of cardiovascular disease. High glucose levels can damage blood vessels and promote inflammation, setting the stage for heart attacks, strokes, and heart failure over time
What did the research discover? This study looked at how a person’s chronotype—whether they are a “morning person” or “night owl”—affects their risk of developing type 2 diabetes and whether lifestyle choices play a role. Researchers followed 63,676 middle-aged nurses who had no history of diabetes, cancer, or heart disease from 2009 to 2017. They divided...